Diversion Control Division, US Department of Justice, Drug Enforcement Administration

Importers Notice of Application - 2019

[Federal Register Volume 84, Number 121 (Monday, June 24, 2019)]
[Pages 29546-29547]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-13377]


Drug Enforcement Administration

[Docket No. DEA-392]

Importer of Controlled Substances Application: VHG Labs DBA LGC Standards

ACTION: Notice of application.

DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before July 24, 2019. Such persons may also file a written request for a hearing on the application on or before July 24, 2019.

[[Page 29547]]

ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on March 6, 2019, VHG Labs DBA LGC Standards, 3 Perimeter Road, Manchester, New Hampshire 03103 applied to be registered as an importer of the following basic classes of controlled substances:

Controlled Substance Drug Code Schedule
Cathinone 1235 I
Methcathinone 1237 I
Naphyrone 1258 I
N-Ethylamphetamine 1475 I
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole) 6250 I
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole) 7008 I
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide 7048 I
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl)indole) 7081 I
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl]indole 7104 I
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) 7118 I
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole) 7122 I
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone 7144 I
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl)indole) 7203 I
Ibogaine 7260 I
Lysergic acid diethylamide 7315 I
Marihuana 7360 I
Mescaline 7381 I
3,4-Methylenedioxymethamphetamine 7405 I
5-Methoxy-N-N-dimethyltryptamine 7431 I
Psilocyn 7438 I
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) 7498 I
Methylone (3,4-Methylenedioxy-N-methylcathinone) 7540 I
Butylone 7541 I
Pentylone 7542 I
Codeine-N-oxide 9053 I
Desomorphine 9055 I
Dihydromorphine 9145 I
Heroin 9200 I
Morphine-N-oxide 9307 I
Normorphine 9313 I
Tilidine 9750 I
Alpha-methylfentanyl 9814 I
Methamphetamine 1105 II
Phenmetrazine 1631 II
Amobarbital 2125 II
Pentobarbital 2270 II
Secobarbital 2315 II
Glutethimide 2550 II
Phencyclidine 7471 II
Phenylacetone 8501 II
Dihydrocodeine 9120 II
Diphenoxylate 9170 II
Ecgonine 9180 II
Ethylmorphine 9190 II
Levorphanol 9220 II
Meperidine 9230 II
Meperidine intermediate-B 9233 II
Meperidine intermediate-C 9234 II
Dextropropoxyphene, bulk (non-dosage forms) 9273 II
14-Hydroxmorphone 9665 II
Noroxymorphone 9668 II
Sufentanil 9740 II

The company plans to import analytical reference standards for distribution to its customers for research and analytical purposes. Placement of these drug codes onto the company's registration does not translate into automatic approval of subsequent permit applications to import controlled substances. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or non- approved finished dosage forms for commercial sale.

Dated: June 6, 2019.

John J. Martin,
Assistant Administrator.

[FR Doc. 2019-13377 Filed 6-21-19; 8:45 am]


NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility